A BILL 
To amend title XVIII of the Social Security Act to ensure 
prompt coverage of breakthrough devices under the Medi-
care program, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Ensuring Patient Ac-
4
cess to Critical Breakthrough Products Act of 2021’’. 
5
17:34 Aug 03, 2021
H4043
2 
•HR 4043 IH
SEC. 2. COVERAGE AND PAYMENT FOR BREAKTHROUGH 
1
DEVICES UNDER THE MEDICARE PROGRAM. 
2
(a) IN GENERAL.—Part E of title XVIII of the Social 
3
Security Act (42 U.S.C. 1395x et seq.) is amended by add-
4
ing at the end the following new section: 
5
‘‘SEC. 1899C. COVERAGE OF BREAKTHROUGH DEVICES. 
6
‘‘(a) BREAKTHROUGH DEVICES.—For purposes of 
7
this section, the term ‘breakthrough device’ means a med-
8
ical device that is a device (as defined in section 201 of 
9
the Federal Food, Drug, and Cosmetic Act) and that is— 
10
‘‘(1) provided with review priority by the Sec-
11
retary under subsection (d)(5) of section 515 of such 
12
Act; and 
13
‘‘(2) approved or cleared pursuant to section 
14
510(k), 513(f), or 515 of such Act for use in treat-
15
ing an indication on or after March 15, 2019. 
16
Such term also includes a breakthrough device that is a 
17
specified breakthrough device (as defined in subsection 
18
(e)(1)(B)) approved or cleared pursuant to section 510(k), 
19
513(f), or 515 of such Act for use in treating an indication 
20
on or after March 15, 2019. 
21
‘‘(b) COVERAGE.— 
22
‘‘(1) TRANSITIONAL COVERAGE.— 
23
‘‘(A) IN
GENERAL.—During the transi-
24
tional coverage period (as defined in subpara-
25
graph (B)) a breakthrough device shall be— 
26
17:34 Aug 03, 2021
H4043
3 
•HR 4043 IH
‘‘(i) deemed to be reasonable and nec-
1
essary 
for 
purposes 
of 
section 
2
1862(a)(1)(A); 
3
‘‘(ii) deemed to be approved for an ad-
4
ditional 
payment 
under 
section 
5
1886(d)(5)(K) (other than with respect to 
6
the cost criterion under clause (ii)(I) of 
7
such section); 
8
‘‘(iii) deemed to be approved for pass- 
9
through payment under section 1833(t)(6) 
10
and section 1833(i) (other than with re-
11
spect to the cost criterion under section 
12
1833(t)(6)(A)(iv)); and 
13
‘‘(iv) insofar as such breakthrough de-
14
vice may be furnished in a setting for 
15
which payment is made under an applica-
16
ble payment system described in subpara-
17
graphs (D) through (I) of subsection 
18
(c)(4), deemed eligible for an additional 
19
payment or payment adjustment, as the 
20
case may be, pursuant to subsection (d)(3) 
21
when furnished in a setting for which pay-
22
ment is made under such an applicable 
23
payment system during such transitional 
24
coverage period. 
25
17:34 Aug 03, 2021
H4043
4 
•HR 4043 IH
‘‘(B) TRANSITIONAL
COVERAGE
PERIOD 
1
DEFINED.—As used in this section, the term 
2
‘transitional coverage period’ means, with re-
3
spect to a breakthrough device, the period 
4
that— 
5
‘‘(i) begins on the date of the approval 
6
under section 515 of the Federal Food, 
7
Drug, and Cosmetic Act or of the clear-
8
ance under section 510(k) of such Act, as 
9
applicable, of such device by the Secretary 
10
for the indication described in subsection 
11
(a)(1); and 
12
‘‘(ii) ends on the last day of the 4- 
13
year period that begins on the date that 
14
the Secretary, pursuant to subsection 
15
(c)(2), updates the relevant applicable pay-
16
ment system (as defined in subsection 
17
(c)(4)) to recognize the unique temporary 
18
or permanent code or codes assigned under 
19
subsection (c)(1) to such breakthrough de-
20
vice, except as provided in subsections 
21
(d)(1)(B) and (d)(2)(B). 
22
‘‘(C) DATA USED TO MEET THE NTAP AND 
23
PASS-THROUGH
COST
CRITERIA.—In 
deter-
24
mining whether a breakthrough device qualifies 
25
17:34 Aug 03, 2021
H4043
5 
•HR 4043 IH
for an additional payment under section 
1
1886(d)(5)(K) or for pass-through payment 
2
under section 1833(t)(6) or section 1833(i), the 
3
Secretary shall use the most recently available 
4
data and information on the costs of such 
5
breakthrough device, which may include list 
6
prices and invoice prices charged for such 
7
breakthrough device. 
8
‘‘(2) PROCESS FOR REGULAR COVERAGE.—For 
9
purposes of the application of section 1862(a)(1)(A) 
10
to a breakthrough device furnished after the transi-
11
tional coverage period (as defined in paragraph 
12
(1)(B)) for such device, the Secretary shall establish 
13
a process for the coverage of such breakthrough de-
14
vices under this title after such period as follows: 
15
‘‘(A) IDENTIFICATION OF ADDITIONAL EVI-
16
DENCE.— 
17
‘‘(i) IN GENERAL.—With respect to a 
18
breakthrough device, not later than 1 year 
19
after the date of the approval of such de-
20
vice under section 515 of the Federal 
21
Food, Drug, and Cosmetic Act or of the 
22
clearance of such device under section 
23
510(k) of such Act, as applicable, the Sec-
24
retary shall identify whether any additional 
25
17:34 Aug 03, 2021
H4043
6 
•HR 4043 IH
data or evidence is required with respect to 
1
any indications for such device for pur-
2
poses of the application of such section 
3
1862(a)(1)(A) to such device for such indi-
4
cations. 
5
‘‘(ii) NON-DUPLICATION OF DATA RE-
6
QUESTS.—In carrying out clause (i) with 
7
respect to a breakthrough device, the Sec-
8
retary shall ensure that data or evidence 
9
identified— 
10
‘‘(I) does not duplicate data re-
11
quired to be collected by the Food and 
12
Drug Administration with respect to 
13
such breakthrough device; 
14
‘‘(II) minimizes the administra-
15
tive burdens of data collection and re-
16
porting on providers of services, sup-
17
pliers, and manufacturers of break-
18
through devices; and 
19
‘‘(III) is not otherwise unneces-
20
sary or redundant. 
21
‘‘(B) PROPOSAL
FOR
COVERAGE
AFTER 
22
THE
TRANSITIONAL
COVERAGE
PERIOD.—Not 
23
later than 2 years after the date of the approval 
24
or clearance of a breakthrough device by the 
25
17:34 Aug 03, 2021
H4043
7 
•HR 4043 IH
Food and Drug Administration, the Secretary 
1
shall develop a proposal for coverage under this 
2
title of such breakthrough device for such indi-
3
cations as the Secretary determines to be ap-
4
propriate, based on the data and evidence col-
5
lected under subparagraph (A), for such devices 
6
furnished after the transitional coverage period 
7
under paragraph (1) for such device. If the Sec-
8
retary does not, on a date that is before the end 
9
of such two-year period, take action to modify 
10
the indications for which coverage of a break-
11
through device may be provided under this title 
12
after such period, for purposes of section 
13
1862(a)(1)(A) coverage under this title of such 
14
breakthrough device shall be made for all indi-
15
cations for which such device is approved under 
16
section 515 of the Federal Food, Drug, and 
17
Cosmetic Act or cleared under section 510(k) of 
18
such Act. 
19
‘‘(3) RULES
OF
CONSTRUCTION.—Nothing in 
20
this section shall be construed to— 
21
‘‘(A) affect the ability of the manufacturer 
22
of a breakthrough device to seek approval for 
23
pass-through payment status under section 
24
1833(t)(6) or to seek approval for an additional 
25
17:34 Aug 03, 2021
H4043
8 
•HR 4043 IH
payment under section 1886(d)(5)(K) insofar 
1
as such breakthrough device does not qualify 
2
for transitional coverage under paragraph (1); 
3
or 
4
‘‘(B) affect the application and approval 
5
process for pass-through payment status under 
6
section 1833(t)(6) or for an additional payment 
7
under section 1886(d)(5)(K) in the case of a 
8
medical device that is not approved by the Food 
9
and Drug Administration as a breakthrough de-
10
vice. 
11
‘‘(c) CODING.— 
12
‘‘(1) PROMPT
ASSIGNMENT.—Not later than 
13
three months after the date of approval or clearance 
14
of a breakthrough device by the Food and Drug Ad-
15
ministration, the Secretary shall assign a unique 
16
temporary or permanent code or codes for purposes 
17
of coverage and payment for such breakthrough de-
18
vice under the applicable payment systems (de-
19
scribed in paragraph (4)). 
20
‘‘(2) UPDATES.— 
21
‘‘(A) IPPS.—The Secretary shall provide 
22
for semiannual updates under the applicable 
23
payment system described in paragraph (4)(A) 
24
(relating to the inpatient hospital prospective 
25
17:34 Aug 03, 2021
H4043
9 
•HR 4043 IH
payment system) to recognize the code or codes 
1
assigned under paragraph (1). 
2
‘‘(B) OPPS.—The Secretary shall provide 
3
for quarterly updates under the applicable pay-
4
ment system described in paragraph (4)(B) (re-
5
lating to the outpatient hospital prospective 
6
payment system) to recognize the code or codes 
7
assigned under paragraph (1). 
8
‘‘(C) OTHER
PAYMENT
SYSTEMS.—The 
9
Secretary shall provide for semiannual or quar-
10
terly updates, as the case may be, under the ap-
11
plicable payment systems described in subpara-
12
graphs (C) through (K) of paragraph (4) to 
13
recognize the code or codes assigned under 
14
paragraph (1). 
15
‘‘(3) TRANSPARENCY.—The process for the as-
16
signment of a code or codes under this subsection 
17
shall provide for public notice and a meaningful op-
18
portunity for public comment from affected parties. 
19
‘‘(4) APPLICABLE
PAYMENT
SYSTEMS
DE-
20
SCRIBED.—For purposes of this subsection, the term 
21
‘applicable payment systems’ means— 
22
‘‘(A) with respect to inpatient hospital 
23
services, the prospective payment system for in-
24
17:34 Aug 03, 2021
H4043
10 
•HR 4043 IH
patient hospital services established under sec-
1
tion 1886(d); 
2
‘‘(B) with respect to outpatient hospital 
3
services, the prospective payment system for 
4
covered OPD services established under section 
5
1833(t); 
6
‘‘(C) with respect to ambulatory surgical 
7
center services, the fee schedule for such serv-
8
ices established under 1833(i); 
9
‘‘(D) with respect to physicians’ services, 
10
the physician fee schedules established under 
11
section 1848; 
12
‘‘(E) with respect to covered items of dura-
13
ble medical equipment, the applicable fee sched-
14
ules established under section 1834; 
15
‘‘(F) with respect to diagnostic laboratory 
16
tests, the payment amounts under section 
17
1834A and the fee schedules establish under 
18
section 1848, as the case may be; 
19
‘‘(G) with respect to inpatient hospital 
20
services furnished by rehabilitation facilities, 
21
the prospective payment system established 
22
under section 1886(j); 
23
‘‘(H) with respect to inpatient hospital 
24
services furnished by long-term care hospitals, 
25
17:34 Aug 03, 2021
H4043
11 
•HR 4043 IH
the prospective payment system under section 
1
1886(m); 
2
‘‘(I) with respect to inpatient hospital serv-
3
ices furnished by psychiatric hospitals and psy-
4
chiatric units, the prospective payment system 
5
under section 1886(s); 
6
‘‘(J) with respect to home health services, 
7
the prospective payment system under section 
8
1895; and 
9
‘‘(K) with respect to items and services, or 
10
a provider of services or supplier, not described 
11
in subparagraphs (A) through (K), the payment 
12
system established under this title for such 
13
items and services when furnished by such pro-
14
vider of services or supplier. 
15
‘‘(d) PAYMENT.— 
16
‘‘(1) INPATIENT HOSPITAL PROSPECTIVE PAY-
17
MENT SYSTEM: DEEMED ELIGIBILITY FOR BREAK-
18
THROUGH
PAYMENT.—The Secretary shall deem 
19
each breakthrough device as approved for an addi-
20
tional payment under section 1886(d)(5)(K) for the 
21
4-year period that begins— 
22
‘‘(A) except as provided in subparagraph 
23
(B), on the date that the Secretary, pursuant to 
24
subsection (c)(2)(A), updates the payment sys-
25
17:34 Aug 03, 2021
H4043
12 
•HR 4043 IH
tem under section 1886(d) to recognize the 
1
unique temporary or permanent code or codes 
2
assigned under subsection (c)(1) to such break-
3
through device; or 
4
‘‘(B) in the case of a device that has not 
5
received approval or clearance as a break-
6
through device by the Food and Drug Adminis-
7
tration before such payment system is updated 
8
under subsection (c)(2)(A) to recognize the 
9
unique temporary or permanent code or codes 
10
assigned under subsection (c)(1) to such device, 
11
on the date of such approval or clearance. 
12
Nothing in this paragraph shall be construed to af-
13
fect the authority of the Secretary to use claims 
14
data to establish new diagnosis or procedure codes 
15
for breakthrough devices or to identify appropriate 
16
diagnosis-related groups for the assignment of 
17
breakthrough devices under annual rulemaking to 
18
carry out section 1886(d)(5)(K). 
19
‘‘(2) OUTPATIENT PROSPECTIVE PAYMENT SYS-
20
TEM: DEEMED
ELIGIBILITY
FOR
PASS-THROUGH 
21
PAYMENT.—The Secretary shall deem each break-
22
through device as approved for pass-through pay-
23
ment under section 1833(t)(6) (including for pur-
24
17:34 Aug 03, 2021
H4043
13 
•HR 4043 IH
poses of section 1833(i)(2)(D)) during the 4-year pe-
1
riod that begins— 
2
‘‘(A) except as provided in subparagraph 
3
(B), on the date that the Secretary, pursuant to 
4
subsection (c)(2)(B), updates the payment sys-
5
tem under section 1833(t) to recognize the 
6
unique temporary or permanent code or codes 
7
assigned under subsection (c)(1) to such break-
8
through device; or 
9
‘‘(B) in the case of a device that has not 
10
received approval or clearance as a break-
11
through device by the Food and Drug Adminis-
12
tration before such payment system is updated 
13
under subsection (c)(2)(B) to recognize the 
14
unique temporary or permanent code or codes 
15
assigned under subsection (c)(1) to such device, 
16
on the date of such approval or clearance. 
17
Nothing in this paragraph shall be construed to af-
18
fect the authority of the Secretary to use claims 
19
data to establish new ambulatory payment classifica-
20
tion groups for breakthrough devices or to revise 
21
such groups to take into account breakthrough de-
22
vices under annual rulemaking to carry out section 
23
1833(t). 
24
‘‘(3) OTHER PAYMENT SYSTEMS.— 
25
17:34 Aug 03, 2021
H4043
14 
•HR 4043 IH
‘‘(A) IN GENERAL.—In the case of break-
1
through device that is furnished and for which 
2
payment may be made under the payment sys-
3
tem established under section 1834, 1834A, 
4
1848, 1886(j), 1886(m), 1886(s), or 1895 or 
5
any other provision of this title (other than sec-
6
tions 1833(i), 1833(t), and 1886(d)), the Sec-
7
retary shall provide for an additional payment 
8
for such breakthrough device under such appli-
9
cable payment system or an adjustment to such 
10
applicable payment system, as the case may be. 
11
The payment basis for such additional payment 
12
or adjustment, as the case may be, shall equal 
13
an amount that the Secretary determines covers 
14
the costs of such breakthrough device. 
15
‘‘(B) COST INFORMATION.—In determining 
16
the costs of a breakthrough device for purposes 
17
of determining an additional payment or pay-
18
ment adjustment under subparagraph (A), the 
19
Secretary shall use the most recently available 
20
data and information on the costs of such 
21
breakthrough device, which may include list 
22
prices and invoice prices charged for such 
23
breakthrough device. 
24
17:34 Aug 03, 2021
H4043
15 
•HR 4043 IH
‘‘(C) RULE OF CONSTRUCTION.—Nothing 
1
in this paragraph shall be construed to affect 
2
the authority of the Secretary to use claims 
3
data to establish new or modify existing ambu-
4
latory payment classification groups, diagnosis- 
5
related groups, level II HCPCS codes or such 
6
other groups or codes as the Secretary may es-
7
tablish under the annual rulemaking authority 
8
under the provisions referred to in subpara-
9
graph (A). 
10
‘‘(D) CLINICAL DIAGNOSTIC LABORATORY 
11
TESTS.—An additional payment or payment ad-
12
justment under subparagraph (A) for a break-
13
through device under the applicable payment 
14
system established in section 1834A may be in 
15
the form of an increase to the amount deter-
16
mined for the breakthrough device using cross- 
17
walking under section 1834A(c)(1)(A), an ex-
18
tension of the initial period of payment applica-
19
ble to advance diagnostic laboratory tests under 
20
section 1834A(d)(1)(A), and in such other form 
21
or manner as the Secretary determines reflects 
22
the costs for such breakthrough device under 
23
the relevant provisions of section 1834A. 
24
17:34 Aug 03, 2021
H4043
16 
•HR 4043 IH
‘‘(4) PAYMENT FOR BREAKTHROUGH DEVICES 
1
AFTER
THE
TRANSITIONAL
COVERAGE
PERIOD.— 
2
Payment for a breakthrough device that is furnished 
3
after the conclusion of the transitional coverage pe-
4
riod under subsection (b)(1) for such device shall be 
5
made pursuant to the applicable payment system in-
6
volved, taking into account the additional evidence 
7
and data collected under subsection (b)(2). 
8
‘‘(e) SPECIAL RULES FOR CERTAIN BREAKTHROUGH 
9
DEVICES.— 
10
‘‘(1) COVERAGE OF SPECIFIED BREAKTHROUGH 
11
DEVICES.— 
12
‘‘(A) IN
GENERAL.—Subject to the suc-
13
ceeding provisions of this subsection and not-
14
withstanding any other provision of law, the 
15
Secretary shall provide for coverage and pay-
16
ment pursuant to this section of a specified 
17
breakthrough device (as defined in subpara-
18
graph (B)). 
19
‘‘(B) SPECIFIED BREAKTHROUGH DEVICE 
20
DEFINED.—In this section, the term ‘specified 
21
breakthrough device’ means a breakthrough de-
22
vice with respect to which no Medicare benefit 
23
category exists. 
24
‘‘(2) PERIOD OF TRANSITIONAL COVERAGE.— 
25
17:34 Aug 03, 2021
H4043
17 
•HR 4043 IH
‘‘(A) IN
GENERAL.—Subject to subpara-
1
graph (C), the provisions of subsection (b)(1) 
2
(relating to the transitional coverage period and 
3
payment for breakthrough devices, including the 
4
use of the most recently available data and in-
5
formation on costs) shall apply to a specified 
6
breakthrough device in the same manner as 
7
such provisions apply to a breakthrough device. 
8
The Secretary may use methodologies under ex-
9
isting payment systems established under this 
10
title, may provide for appropriate adjustments 
11
to such methodologies, or may establish a new 
12
payment methodology under this title, to pro-
13
vide for payment for a specified breakthrough 
14
device to ensure the payment basis for such 
15
payment covers costs of the specified break-
16
through device are covered by such payment. 
17
‘‘(B) REPORT.— 
18
‘‘(i) IN
GENERAL.—With respect to 
19
each specified breakthrough device, the 
20
Secretary shall submit to Congress a re-
21
port on the coverage of and payment for 
22
such specified breakthrough device under 
23
this section that includes the following in-
24
formation: 
25
17:34 Aug 03, 2021
H4043
18 
•HR 4043 IH
‘‘(I) The manner in which cov-
1
erage is provided and payment is 
2
made for the specified breakthrough 
3
device, including how such device was 
4
classified (such as an item of durable 
5
medical equipment or otherwise) and 
6
the payment methodology the Sec-
7
retary applied with respect to such de-
8
vice. 
9
‘‘(II) The impact of the avail-
10
ability of the specified breakthrough 
11
device to Medicare beneficiaries, in-
12
cluding impacts on the quality of pa-
13
tient care, patient outcomes, and pa-
14
tient experience. 
15
‘‘(III) The impact of the avail-
16
ability of the specified breakthrough 
17
device to Medicare beneficiaries on 
18
program expenditures under this title. 
19
‘‘(IV) Such other information as 
20
the Secretary determines to be appro-
21
priate. 
22
‘‘(ii) DEADLINE.— 
23
‘‘(I) IN
GENERAL.—Except as 
24
provided in subclause (II), the Sec-
25
17:34 Aug 03, 2021
H4043
19 
•HR 4043 IH
retary shall submit a report required 
1
under this subparagraph no later than 
2
the end of the transitional period of 
3
coverage and payment applicable to 
4
such specified breakthrough device. 
5
‘‘(II) EXTENSION TO GENERATE 
6
ADDITIONAL DATA.—If the Secretary 
7
determines that additional data or evi-
8
dence is required to complete a report 
9
required under this subparagraph 
10
with respect to a specified break-
11
through device, the deadline under 
12
this clause may be extended for an 
13
additional two years. 
14
‘‘(C) ADDITIONAL
PERIOD
OF
TRANSI-
15
TIONAL
COVERAGE
TO
DEVELOP
ADDITIONAL 
16
DATA.—Insofar as the Secretary determines 
17
that additional data or evidence is required to 
18
complete a report required under subparagraph 
19
(B) with respect to a specified breakthrough de-
20
vice, the transitional coverage period of cov-
21
erage and payment for such device shall be ex-
22
tended by the lesser of— 
23
‘‘(i) two years; or 
24
17:34 Aug 03, 2021
H4043
20 
•HR 4043 IH
‘‘(ii) the amount of additional time re-
1
quired for the submission of the report 
2
with respect to such device. 
3
‘‘(3) COVERAGE
AND
PAYMENT
AFTER
THE 
4
TRANSITIONAL
PERIOD.—The Secretary may con-
5
tinue to provide for coverage of and payment for a 
6
specified breakthrough device after the end of the 
7
transitional period of coverage and payment for 
8
breakthrough devices through the national coverage 
9
determination process if the Secretary determines 
10
that the specified breakthrough device— 
11
‘‘(A) improves the quality of care and pa-
12
tient outcomes; 
13
‘‘(B) improves the delivery of care; or 
14
‘‘(C) reduces spending under this title 
15
without reducing the quality of care.’’. 
16
(b) CONFORMING AMENDMENTS.— 
17
(1) INPATIENT
PROSPECTIVE
PAYMENT
SYS-
18
TEM.—Section 1886(d)(5)(K) of the Social Security 
19
Act (42 U.S.C. 1395ww(d)(5)(K)) is amended by 
20
adding at the end the following new clause: 
21
‘‘(x) Effective for discharges occurring on 
22
or after October 1, 2019, in the case of a new 
23
medical service or technology that is a break-
24
through 
device 
(as 
defined 
in 
section 
25
17:34 Aug 03, 2021
H4043
21 
•HR 4043 IH
1899C(a)), the additional payment established 
1
for such breakthrough device under this sub-
2
paragraph shall be made for the 4-year period 
3
applicable to such breakthrough device under 
4
section 
1899C(d)(1). 
In 
determining 
the 
5
amount of the additional payment for a break-
6
through device under this subparagraph during 
7
such 4-year period, the Secretary shall apply 
8
section 412.88(b) of title 42, Code of Federal 
9
Regulations, as in effect on the date of the en-
10
actment of this clause, except as if the ref-
11
erence in such section to ‘65 percent’ were a 
12
reference to ‘65 percent (or such greater per-
13
cent specified by the Secretary)’.’’. 
14
(2) OUTPATIENT PROSPECTIVE PAYMENT SYS-
15
TEM.—Section 1833(t)(6)(C) of such Act (42 U.S.C. 
16
1395l(t)(6)(C)) is amended by adding at the end the 
17
following new clause: 
18
‘‘(iii) SPECIAL
RULE
FOR
BREAK-
19
THROUGH
DEVICES.—Notwithstanding 
20
clause (i) or (ii), or any other provision of 
21
this paragraph to the contrary, in the case 
22
of a breakthrough device (as defined in 
23
section 1899C(a)) that is furnished on or 
24
after January 1, 2020, payment under this 
25
17:34 Aug 03, 2021
H4043
22 
•HR 4043 IH
paragraph for such breakthrough device 
1
shall be made for the 4-year period appli-
2
cable to such breakthrough device under 
3
section 1899C(d)(2). The provisions of this 
4
clause shall also apply for purposes of 
5
transitional pass-through payment under 
6
section 1833(i)(2)(D).’’. 
7
(c) EFFECTIVE DATE.—This section, and the amend-
8
ments made by this section, shall take effect on the date 
9
of the enactment of this Act and, unless otherwise speci-
10
fied in this section (or in an amendment made by this sec-
11
tion), shall apply to breakthrough devices (as defined in 
12
section 1899C(a) of the Social Security Act, as added by 
13
subsection (a)), approved or cleared on or after July 1, 
14
2019, or, in the case of a specified breakthrough device 
15
(as defined in such section as so added), approved or 
16
cleared on or after December 1, 2018. 
17
Æ 
17:34 Aug 03, 2021
H4043
